NCT06243848 Comparison of Ultrasound-Guided Injection With Median Nerve Decompression Surgery in Carpal Tunnel Syndrome
| NCT ID | NCT06243848 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Afyonkarahisar Health Sciences University |
| Condition | Musculoskeletal Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-01-25 |
| Primary Completion | 2026-04-24 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-01-25 with a primary completion date of 2026-04-24.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to compare ultrasound-guided perineural injection of the median nerve with classic minimal incision surgical technique for median nerve decompression in patients diagnosed with mild, moderate, and severe carpal tunnel syndrome.
Eligibility Criteria
Inclusion Criteria: * The presence of symptoms such as nocturnal, posture-related, or movement-related paresthesias, along with possible pain, in the area supplied by the median nerve in the hand, lasting for more than 3 months. * Confirmation of mild, moderate or severe CTS through electrophysiological testing. * Numbness and loss of sensation in the hand's regions innervated by the median nerve, as well as weakness in the thenar muscles innervated by the median nerve. * Positive results on either the Phalen test and/or Tinel sign. Exclusion Criteria: * Individuals who may exhibit symptoms mimicking carpal tunnel syndrome, such as cervical radiculopathy, polyneuropathy, brachial plexopathy, or thoracic outlet syndrome. * Patients who have received a previous injection into the carpal tunnel within the past 6 months. * Thenar muscle atrophy. * A history of prior carpal tunnel surgery. * Regular usage of systemic nonsteroidal anti-inflammatory drugs and corticosteroids. * Pregnancy * Patients diagnosed with rheumatoid arthritis, systemic lupus erythematosus, gout, systemic sclerosis, dermatomyositis, or polymyositis. * Malignancy. * Active infections
Contact & Investigator
Nuran EYVAZ, MD
PRINCIPAL INVESTIGATOR
Afyonkarahisar Health Sciences University
Frequently Asked Questions
Who can join the NCT06243848 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Musculoskeletal Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06243848 currently recruiting?
Yes, NCT06243848 is actively recruiting participants. Contact the research team at dr.akcin93@gmail.com for enrollment information.
Where is the NCT06243848 trial being conducted?
This trial is being conducted at Afyonkarahisar, Turkey (Türkiye).
Who is sponsoring the NCT06243848 clinical trial?
NCT06243848 is sponsored by Afyonkarahisar Health Sciences University. The principal investigator is Nuran EYVAZ, MD at Afyonkarahisar Health Sciences University. The trial plans to enroll 60 participants.